Chemoradiotherapy Sequenced Radical Surgery for Colorectal Cancer With PALNM
NCT05129774 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2021-11-22
Summary
In left-sided colon and rectal cancer, the occurrence of synchronous para-aortic lymph node metastasis is rare, with the incidence of being approximate 1-2%. Currently, there has been no standard treatment strategy for this situation. The present trial is designed to evaluate the safety and efficacy of para-aortic lymph node dissection for left-sided colon and rectal cancer with synchronous para-aortic lymph node metastasis
Conditions
- Colorectal Neoplasms Malignant
- Lymph Node Excision
- Chemoradiotherapy
Interventions
- PROCEDURE
-
Radical surgery with PALND
sufficient resection margins of the tumor, D3 dissection of the regional lymph nodes and para-aortic lymph node dissection from the bifurcation of iliac artery to the left renal vein via laparoscopic approach
- PROCEDURE
-
Radical surgery without PALND
surgery includes sufficient resection margins of the tumor and D3 dissection of the regional lymph nodes without PALND
Sponsors & Collaborators
-
Qilu Hospital of Shandong University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- SEQUENTIAL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-01-01
- Primary Completion
- 2024-01-01
- Completion
- 2027-01-01
Countries
- China
Study Locations
More Related Trials
-
Postoperation Maintenance Therapy for Resectable Liver Metastases of Colorectal Cancer Guided by ctDNA
NCT05797077 ·Status: RECRUITING ·Phase: PHASE3
-
CRT Versus Surgery for Retroperitoneal or Paraaortic Lymph Node Recurrence of CRC
NCT03725254 ·Status: UNKNOWN ·Phase: PHASE2
-
Node-Sparing Low-Dose Radiotherapy Concurrent With Chemotherapy and PD-1 Inhibitor in pMMR/MSS High-Risk Locally Advanced Colon Cancer: A Prospective, Single-Arm, Phase II Trial
NCT07279077 ·Status: RECRUITING ·Phase: PHASE2
-
Extended Resection for Rectal Cancer With Neoadjuvant Radiotherapy
NCT05267275 ·Status: RECRUITING ·Phase: NA
-
Extent of Lymph Node Dissection for Advanced Right-Sided Colon Cance
NCT06986538 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
New Adjuvant Chemotherapy of Asymptomatic Resectable Primary Lesion With Unresectable Liver-limited Metastases
NCT01307878 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of PD-1 ± mFOLFOX6 Neoadjuvant Therapy in Local Advanced sMPCC
NCT06002789 ·Status: RECRUITING ·Phase: PHASE2
-
Regorafenib Plus Raltitrexed as Third-line Treatment in Advanced Colorectal Cancer Patients
NCT05426811 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Preserving Left Colonic Artery During Radical Resection of Rectal Cancer
NCT03776370 ·Status: COMPLETED
-
Maintenance Tislelizumab + Capecitabine to Treat Metastatic Colorectal Cancer
NCT05360277 ·Status: RECRUITING ·Phase: PHASE2
-
Neoadjuvant Chemoradiotherapy Versus Neoadjuvant Chemotherapy For Unresectable Locally Advanced Colon Cancer
NCT03970694 ·Status: TERMINATED ·Phase: PHASE3
-
Real-world Retrospective Data Analysis of Adjuvant Therapy for Patients With Stage II-III Colon Cancer After Radical Surgery
NCT03958435 ·Status: UNKNOWN
-
Neoadjuvant Triplet Chemotherapy Regimen in Patients With Resectable Colorectal Cancer
NCT02688023 ·Status: UNKNOWN ·Phase: PHASE2
-
The Value of Palliative Primary Tumor Resection in Metastatic Colon Cancer
NCT04416854 ·Status: RECRUITING ·Phase: PHASE3
-
Chemoradiotherapy Combined With or Without PD-1 Blockade in Anal Canal Squamous Carcinoma Patients
NCT05374252 ·Status: RECRUITING ·Phase: PHASE3
-
Radiation Therapy, Chemotherapy, and Cetuximab Followed by Surgery, Chemotherapy, and Cetuximab in Treating Patients With Locally Advanced or Metastatic Rectal Cancer That Can Be Removed by Surgery
NCT00541112 ·Status: TERMINATED ·Phase: PHASE2
-
Application of Two Anti-angiogenesis Drugs Combined With Chemotherapy in Advanced Colorectal Cancer Under the Background of Precision Medical
NCT02748772 ·Status: UNKNOWN ·Phase: PHASE3
-
Randomized Trial of Primary Surgery Followed Selective Radiochemotherapy for Rectal Cancer With MRI Negative CRM
NCT02121405 ·Status: SUSPENDED ·Phase: PHASE3
-
Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and PCSK9 Inhibitor for pMMR/MSS Locally Advanced Mid-low Rectal Cancer
NCT06304987 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Total Neoadjuvant Chemoradiotherapy Plus Anti-PD-1 in Subperitoneal Patients With Locally Advanced Rectal CancerPatients With Locally Advanced Rectal Cancer: A Prospective, Single Arm, Exploratory Study
NCT05998122 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Chemotherapy and Tislelizumab With Split-course HFRT for Locally Advanced Rectal Cancer
NCT05176964 ·Status: RECRUITING
-
The Real Clinical Background of Advanced Colorectal Cancer Treatment Situation Survey
NCT01549067 ·Status: UNKNOWN
-
Effectiveness Study of Resection of Primary Tumor in Stage IV Colorectal Cancer Patients
NCT02149784 ·Status: UNKNOWN ·Phase: PHASE3
-
Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for Colorectal Cancer Liver Metastases
NCT02419677 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Lateral Lymph Node Dissection After Neoadjuvant Chemo-radiation in Advanced Low Rectal Cancer
NCT02614157 ·Status: TERMINATED ·Phase: NA